These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8624172)

  • 1. Acute pancreatitis associated with sodium stibogluconate treatment in a patient with human immunodeficiency virus.
    Domingo P; Ferrer S; Kolle L; Muñoz C; Rodriguez P
    Arch Intern Med; 1996 May; 156(9):1029, 1032. PubMed ID: 8624172
    [No Abstract]   [Full Text] [Related]  

  • 2. Pancreatic necrosis following treatment of leishmaniasis with sodium stibogluconate.
    McBride MO; Linney M; Davidson RN; Weber JN
    Clin Infect Dis; 1995 Sep; 21(3):710. PubMed ID: 8527590
    [No Abstract]   [Full Text] [Related]  

  • 3. [Acute pancreatitis due to antimonials in patients with visceral leishmaniasis and HIV infection].
    Cortés E; Ribera E; Cucurull E; de Otero J; Ocaña I; Pahissa A
    Med Clin (Barc); 1995 Apr; 104(15):578-80. PubMed ID: 7769868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sodium stibogluconate.
    Shrestha NK
    Clin Infect Dis; 2006 Nov; 43(10):1371-2. PubMed ID: 17051510
    [No Abstract]   [Full Text] [Related]  

  • 5. Successful use of miltefosine and sodium stibogluconate, in combination, for the treatment of an HIV-positive patient with visceral leishmaniasis: a case report and brief review of the literature.
    Collini P; Premchand N; Lockwood D; Greig J
    Ann Trop Med Parasitol; 2009 Jul; 103(5):455-9. PubMed ID: 19583915
    [No Abstract]   [Full Text] [Related]  

  • 6. Sodium antimony gluconate, amphotericin, and myocardial damage.
    Thakur CP
    Lancet; 1998 Jun; 351(9120):1928-9. PubMed ID: 9654264
    [No Abstract]   [Full Text] [Related]  

  • 7. [Nephrotic syndrome and acute pancreatitis related to glucantime administration].
    Valencia ME; Laguna F; González Lahoz J
    An Med Interna; 2000 Jan; 17(1):54. PubMed ID: 10730416
    [No Abstract]   [Full Text] [Related]  

  • 8. Safety and efficacy of intravenous sodium stibogluconate in the treatment of leishmaniasis: recent U.S. military experience.
    Aronson NE; Wortmann GW; Johnson SC; Jackson JE; Gasser RA; Magill AJ; Endy TP; Coyne PE; Grogl M; Benson PM; Beard JS; Tally JD; Gambel JM; Kreutzer RD; Oster CN
    Clin Infect Dis; 1998 Dec; 27(6):1457-64. PubMed ID: 9868660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Acute pancreatitis with a fatal evolution due to antimonials in patients with visceral leishmaniasis and HIV infection].
    Santos J; Rivero A; Márquez M
    An Med Interna; 2000 Oct; 17(10):562-3. PubMed ID: 11109659
    [No Abstract]   [Full Text] [Related]  

  • 10. Post-treatment fulminant hepatic failure in an infant with Visceral leishmaniasis: Immune injury or stibogluconate toxicity?
    Baranwal AK; Ravi RN; Singh R
    Indian J Pediatr; 2010 Jan; 77(1):107-8. PubMed ID: 19936650
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of Indian Kala-azar with pentavalent antimony.
    Domingo P; Ferrer S; Kolle L; Muñoz C; Sambeat MA
    Lancet; 1995 Mar; 345(8949):584-5. PubMed ID: 7776793
    [No Abstract]   [Full Text] [Related]  

  • 12. Meglumine antimoniate-induced pancreatitis.
    Torrús D; Massa B; Boix V; Portilla J; Pérez-Mateo M
    Am J Gastroenterol; 1996 Apr; 91(4):820-1. PubMed ID: 8677970
    [No Abstract]   [Full Text] [Related]  

  • 13. Pancreatitis occurring during therapy with stibogluconate: two case reports.
    McCarthy AE; Keystone JS; Kain KC
    Clin Infect Dis; 1993 Nov; 17(5):952-3. PubMed ID: 7741821
    [No Abstract]   [Full Text] [Related]  

  • 14. Visceral leishmaniasis in clinical practice.
    Davidson RN
    J Infect; 1999 Sep; 39(2):112-6. PubMed ID: 10609527
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparison of generic and proprietary sodium stibogluconate for the treatment of visceral leishmaniasis in Kenya.
    Moore E; O'Flaherty D; Heuvelmans H; Seaman J; Veeken H; de Wit S; Davidson RN
    Bull World Health Organ; 2001; 79(5):388-93. PubMed ID: 11417033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pancreatitis induced by pentavalent antimonial agents during treatment of leishmaniasis.
    Gasser RA; Magill AJ; Oster CN; Franke ED; Grögl M; Berman JD
    Clin Infect Dis; 1994 Jan; 18(1):83-90. PubMed ID: 7519887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conduction defect following pentavalent antimony therapy in visceral leishmaniasis.
    Ahasan HA; Chowdhury MA; Azhar MA; Rafiqueuddin AK; Islam F
    Trop Doct; 1997 Jan; 27(1):59-61. PubMed ID: 9030031
    [No Abstract]   [Full Text] [Related]  

  • 18. Antimony-induced cerebellar ataxia.
    Khalil EA; Ahmed AE; Musa AM; Hussein MH
    Saudi Med J; 2006 Jan; 27(1):90-2. PubMed ID: 16432602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of liposomal amphotericin B with sodium stibogluconate for the treatment of visceral leishmaniasis in pregnancy in Sudan.
    Mueller M; Balasegaram M; Koummuki Y; Ritmeijer K; Santana MR; Davidson R
    J Antimicrob Chemother; 2006 Oct; 58(4):811-5. PubMed ID: 16916865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful treatment of visceral leishmaniasis with allopurinol plus ketoconazole in a renal transplant recipient after the occurrence of pancreatitis due to stibogluconate.
    Halim MA; Alfurayh O; Kalin ME; Dammas S; al-Eisa A; Damanhouri G
    Clin Infect Dis; 1993 Mar; 16(3):397-9. PubMed ID: 8135901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.